Question : Types of Vaccines

(a) the number of people given double dose and those given single dose of COVID-19 vaccination, State/UT/dose-wise as on November 2021:
(b) the different vaccines being used in India to vaccinate the population;
(c) whether the Government proposes to introduce a single dose vaccine, if so, the details thereof and the time by which the Government is expected to vaccinate the whole population with a single dose;
(d) whether the Indian manufacturers have been allowed to export vaccines to the other countries, if so, the details thereof; and
(e) whether the Government is aware that a large number of vaccines are getting expired due to lack of proper distribution and storage facilities in different State/UTs, if so, the details thereof and the steps taken in this regard?

THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE
(DR. BHARATI PRAVIN PAWAR)

(a) By 30th November 2021, 78.90 crore beneficiaries (84.0%) aged 18 years and above have received at least one dose of COVID-19 vaccine and 45.20 crore (48.1%) have received both the doses. The State/UT-wise details are at Annexure-1.
(b) and (c) COVID-19 vaccines which have received approval for Restricted Use under Emergency Situation from the National Regulator i.e. Central Drugs Standard Control Organization (CDSCO), are used under the National COVID-19 Vaccination Program. Presently, three vaccines are used in Covid-19 vaccination program, namely, Covishiled, Covaxin and Sputnik V, all of which are two dose vaccines.
(d) to (e) India started external supplies of Made in India COVID-19 vaccines under Vaccine Maitri initiative on January 20,2021 in the form of grants-in-aid and commercial sales by Indian manufacturers and through GAVI’s COVAX facility. Indian companies have significantly enhanced their vaccine production capacity and are in a position to meet domestic requirements of COVID-19 vaccines as also contribute their surplus production to global Covid-19 vaccination requirements.
Government of India closely monitors COVID-19 vaccine stocks in States/UTs so as to ensure their optimal utilization. State/UTs have been advised to closely monitor and utilize the near expiry vaccine doses. The cold chain storage space was augmented at the start of the vaccination program and is sufficient to meet the vaccine requirement of both COVID-19 vaccination as well as routine immunization.